Roche and AC Immune’s Alzheimer’s drug on right track
Alzheimer's, Genentech, neurology, Roche
0 Comment
Data suggest high dose used in phase 3 trial is most effective
Roche
Alvogen launches Tamiflu generic in US
Alvogen, flu, infectious diseases, influenza, Roche
0 Comment
Generic was developed with India’s Natco.
Roche launches cancer immunotherapy R&D network
Bristol-Myers Squibb, cancer immunotherapy, Merck & Co, Roche
0 Comment
Initiative aims to find new immunotherapies.
Novartis could sell Alcon eyecare business
Alcon, M&A, Novartis, ophthalmology, Roche
0 Comment
Swiss pharma looks to offload struggling division.
Roche to file Actemra in inflamed artery disease
cardiovascular, fda, filing, giant cell arteritis, Roche
0 Comment
Drug successful in late stage trial for giant cell arteritis
Embattled Mylan files Herceptin biosimilar in US
biosimilar, Mylan, pricing, Roche
0 Comment
But senators call for investigation into EpiPen schools contracts.
Roche muscling into melanoma with Tecentriq
bladder cancer, cancer, R&D, Roche, sales, skin cancer
0 Comment
Swiss pharma looking to combine immunotherapy with already marketed drugs.
Three’s a crowd as Tecentriq approved in lung cancer
cancer, cancer immunotherapy, Genentech, immuno-oncology, lung cancer, Roche
0 Comment
Cancer immunotherapy approved in second line.
